<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00312884</url>
  </required_header>
  <id_info>
    <org_study_id>2006EP001B</org_study_id>
    <secondary_id>05/Q0411/112</secondary_id>
    <nct_id>NCT00312884</nct_id>
  </id_info>
  <brief_title>Home-HF: Evaluation of Patients With Heart Failure Using Home Telemonitoring</brief_title>
  <official_title>Home-HF: a Randomised Controlled Evaluation of Home Telemonitoring of Patients With Heart Failure Recently Discharged From Hospital.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Honeywell HomMed</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <brief_summary>
    <textblock>
      This project, using home monitoring for the signs and symptoms of heart failure, aims to
      empower patients to be actively involved in their care and provide rapid access to healthcare
      services and advice when needed. The telemonitoring system is easy to use and ensures the
      accurate transfer of information from the home to the hospital. The information is then
      screened and if important changes are seen, the patient will be contacted by a heart failure
      nurse who will offer advice and may arrange a clinic visit or suggest alterations to the
      medication. The project uses modern technology to provide disease management, links the
      patient in their home with the hospital and reinforces education and self-care behaviour.
      This innovative programme will be tested to see if it reduces the risk of re-admission to
      hospital, reduces anxiety, improves quality of life following a hospital admission for heart
      failure and whether this represents good value for money in terms of the health benefits it
      provides.

      Hypothesis:

      Patients using home telemonitoring of signs and symptoms of heart failure following discharge
      from hospital with chronic heart failure have a reduced risk of all-cause re-hospitalisation
      when compared with usual care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project, using home monitoring for the signs and symptoms of heart failure, aims to
      empower patients to be actively involved in their care and provide rapid access to healthcare
      services and advice when needed. This innovative programme will be tested to see if it
      reduces the risk of re−admission to hospital. In addition economic evaluation will assess
      whether this represents good value for money in terms of the health benefits it provides.

      After fulfilling the inclusion criteria and being consented into the study, the patients will
      be randomised into either the control or intervention group in a 1:1 ratio.

      Intervention Group:

      Prior to hospital discharge the patient and carer/family will be shown how to use the HomMed
      Telemonitoring equipment. Within two working days of discharge the equipment will be
      installed in their home by the study nurse who will remind them of its use. They will be
      provided with a written management plan and advice regarding self−monitoring.They will be
      asked to monitor signs and symptoms of their disease daily using the HomMed telemonitoring
      system connected to their home phone line.

      The data will be reviewed every working day by a study nurse and examined for variance from
      the agreed parameters. If clinically significant changes are noted a standard protocol will
      be used to guide the management.

      Control group:

      Within two working days of discharge the study nurse will visit patients in the control group
      and provide them with a written management plan and advice regarding self−monitoring. They
      will receive usual care for that centre which will consist of a recommendation to visit their
      GP on hospital discharge and a subsequent review in the outpatient clinic. Informal support
      offered through the hospital heart failure nurse will continue and this contact will be
      recorded.

      Within both groups the Hospital Anxiety and Depression (HAD) questionnaire, the Minnesota
      Living with Heart Failure(MLWHF) tool and the Euroqol (EQ−5D) questionnaire will be completed
      at randomisation, and again at 3 and 6 months following hospital discharge. They will be
      asked to return completed questionnaires in a pre−paid envelope.

      Data on patients' use of healthcare services will be collected from both groups using a
      combination of retrospective questionnaires and prospective health diaries, which will be
      returned at 3 and 6 months after randomisation.

      Drug optimisation will be assessed through review of medication prescription, and drug
      utilisation through patient self−report.These data will also be collected at 3 and 6 months.

      Patients within both groups will be involved in the study for a period of 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Days Alive and Outside of Hospital</measure>
    <time_frame>From date of randomisation for 180 days</time_frame>
    <description>Days alive and outside of hospital (i.e. not admitted)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patients Hospitalised (All Cause)</measure>
    <time_frame>From randomisation date to 180 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Days Spent in Hospital</measure>
    <time_frame>From randomisation date for 180 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Hospitalisations (All Cause)</measure>
    <time_frame>from randomisation for 180 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">182</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Recieved usual hospital and community care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recieved telemonitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HomMed Telemonitoring System</intervention_name>
    <description>The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_label>Intervention Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NYHA class II - IV (i.e. breathlessness at rest or on mild-moderate exercise) at time
             of randomisation (hospital discharge)

          -  Proven diagnosis of heart failure, in line with the guidelines for management of
             chronic heart failure of the European Society of Cardiology or as determined by the
             cardiologist or physician caring for the patient

          -  Admission to hospital following a new diagnosis of heart failure or episode of acute
             decompensation of chronic heart failure

          -  Home telephone line

          -  Deemed fit for discharge home by the clinical team

        Exclusion Criteria:

          -  Dementia/confusion which is likely to interfere with the use of the HomMed
             telemonitoring equipment.

          -  &lt; 18 years of age

          -  Lack of home telephone line
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin R Cowie, MD MSc FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London &amp; Royal Brompton and Harefield Hospital NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West Middlesex University Hospital</name>
      <address>
        <city>Greater London</city>
        <state>Middlesex</state>
        <zip>TW7 6AF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ealing Hospital</name>
      <address>
        <city>London</city>
        <zip>UB1 3HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hillingdon Hospital</name>
      <address>
        <city>Uxbridge</city>
        <zip>UB8 3NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2006</study_first_submitted>
  <study_first_submitted_qc>April 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2006</study_first_posted>
  <results_first_submitted>October 27, 2015</results_first_submitted>
  <results_first_submitted_qc>April 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 30, 2016</results_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>telemonitoring</keyword>
  <keyword>heart failure</keyword>
  <keyword>randomised</keyword>
  <keyword>hospitalisation</keyword>
  <keyword>HomMed</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention Arm</title>
          <description>Recieved home telemonitoring daily HomMed Telemonitoring System: The HomeMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Received usual hospital care with no Telemonitoring</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="79"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Recieved usual follow-up care</description>
        </group>
        <group group_id="B2">
          <title>Intervention Arm</title>
          <description>Received daily home monitoring</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="91"/>
            <count group_id="B2" value="91"/>
            <count group_id="B3" value="182"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72" spread="10.4"/>
                    <measurement group_id="B2" value="70" spread="12.8"/>
                    <measurement group_id="B3" value="71" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Days Alive and Outside of Hospital</title>
        <description>Days alive and outside of hospital (i.e. not admitted)</description>
        <time_frame>From date of randomisation for 180 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Recieved usual hospital and community care
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
          <group group_id="O2">
            <title>Intervention Arm</title>
            <description>Recieved telemonitoring
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
        </group_list>
        <measure>
          <title>Days Alive and Outside of Hospital</title>
          <description>Days alive and outside of hospital (i.e. not admitted)</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="180" lower_limit="165" upper_limit="180"/>
                    <measurement group_id="O2" value="178" lower_limit="90" upper_limit="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patients Hospitalised (All Cause)</title>
        <time_frame>From randomisation date to 180 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Recieved usual hospital and community care
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
          <group group_id="O2">
            <title>Intervention Arm</title>
            <description>Recieved telemonitoring
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
        </group_list>
        <measure>
          <title>Patients Hospitalised (All Cause)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Days Spent in Hospital</title>
        <time_frame>From randomisation date for 180 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Recieved usual hospital and community care
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
          <group group_id="O2">
            <title>Intervention Arm</title>
            <description>Recieved telemonitoring
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days Spent in Hospital</title>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="6" upper_limit="25"/>
                    <measurement group_id="O2" value="13" lower_limit="8" upper_limit="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Hospitalisations (All Cause)</title>
        <time_frame>from randomisation for 180 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Recieved usual hospital and community care
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
          <group group_id="O2">
            <title>Intervention Arm</title>
            <description>Recieved telemonitoring
HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Hospitalisations (All Cause)</title>
          <units>Number of hospitalisations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse events were collected without regard for teh specific adverse event term.</desc>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Recieved usual hospital care</description>
        </group>
        <group group_id="E2">
          <title>Intervention Arm</title>
          <description>Recieved telemonitoring daily via the HomMed Telemonitoring System: The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="91"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <description>All cause hospitalisation</description>
                <counts group_id="E1" events="39" subjects_affected="23" subjects_at_risk="91"/>
                <counts group_id="E2" events="44" subjects_affected="33" subjects_at_risk="91"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="91"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart Failure Admission</sub_title>
                <counts group_id="E1" events="16" subjects_affected="10" subjects_at_risk="91"/>
                <counts group_id="E2" events="22" subjects_affected="17" subjects_at_risk="91"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Cowie</name_or_title>
      <organization>Imperial College london</organization>
      <phone>0207 349 7716</phone>
      <email>m.cowie@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

